Cite
MLA Citation
Jae-Hyeog Choi et al.. “A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice.” Oncoimmunology, vol. 7, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100059682572.0x00000e